Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Active, not recruiting

Conditions: Miscarriage, Recurrent

Treatments: Dietary Supplement: Bifidobacterium Longum ES1

Study type: Interventional

Funder types: Other

Identifiers

NCT06867900

1355

Details and patient eligibility

About

Evaluation of gut permeability and endometrial inflammasome NLRP3 in women with unexplaid recurrent pregnancy loss before-after administration of Bifidobacteriumlongum ES1.

Enrollment: 22 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Idiopathic recurrent pregnancy loss
• Genetic predisposition to celiac disease

Exclusion criteria

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

Bifidobacterium Longum

Experimental group

Treatment:

Dietary Supplement: Bifidobacterium Longum ES1